Literature DB >> 17723299

Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase.

Peter Jan Zimmermann1, Wilm Buhr, Christof Brehm, Andreas Marc Palmer, Martin Philipp Feth, Jörg Senn-Bilfinger, Wolfgang-Alexander Simon.   

Abstract

A series of novel 8-indanylamino- and 8-indanyloxy-substituted imidazo[1,2-a]pyridines with reduced lipophilicity was synthesized from easily accessible starting compounds. The anti-secretory activity of these compounds has been assessed in a competitive binding assay against H(+)/K(+)-ATPase from hog gastric mucosa. Some of the compounds proved to be potent inhibitors of the gastric acid pump.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723299     DOI: 10.1016/j.bmcl.2007.08.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  A Quantitative Structure-Activity Relationship and Molecular Modeling Study on a Series of Heteroaryl- and Heterocyclyl-Substituted Imidazo[1,2-a]Pyridine Derivatives Acting as Acid Pump Antagonists.

Authors:  Neeraj Agarwal; Anubha Bajpai; Satya P Gupta
Journal:  Biochem Res Int       Date:  2013-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.